202610月
PODD Oct 2026 · Buy
Insulet Corporation presents an attractive investment opportunity in medical technology infrastructure, combining a high-margin recurring consumable model with expanding international and Type 2 diabetes adoption at an 18.74% discount to Fair value.Latest published research · analyzed 2026-10-14 · current · sources aging